Catalyst Wire Dossier Catalyst Wire Dossier

LEADER 12 HOUR SINUS NASAL DECONGESTANT

Pseudoephedrine hydrochloride · Cardinal Health 110, LLC. dba Leader
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LEADER 12 HOUR SINUS NASAL DECONGESTANT, covering 2011-05-24 to 2011-05-24. Get the full timeline:

Most recent: FDA Approved: LEADER 12 HOUR SINUS NASAL DECONGESTANT — Supplemental Application (Cardinal Health 110, LLC. dba Leader)

See pricing